Physician

Luke Stewart Wallis, MD

According to 2025 Medicare claims, Luke Wallis, MD (NPI: 1144724717) practices dermatology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is WALLIS DERMATOLOGY ASSOCIATES PLLC (NPI: 1396945234; TIN: 454041922) and primary practice location at 75605-0038.

Wallis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 671 traditional Medicare patients, billed 10,828 HCPCS/CPT codes, and received $1,469,811 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 988 prescription claims across 486 beneficiaries totaling $579,025 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 94 records totaling $2,040. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,573 to $579,025. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$735K$1.5M2023 Medicare payment: $223,516 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,469,811 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20234306,560$223,516
202467110,828$1,469,811

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$290K$579K2018 Drug cost: $1,573 (USD; Tot_Drug_Cst)2019 Drug cost: $103,721 (USD; Tot_Drug_Cst)2020 Drug cost: $210,592 (USD; Tot_Drug_Cst)2021 Drug cost: $67,637 (USD; Tot_Drug_Cst)2022 Drug cost: $63,158 (USD; Tot_Drug_Cst)2023 Drug cost: $43,321 (USD; Tot_Drug_Cst)2024 Drug cost: $579,025 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181220$1,573
20192847$103,721
20204791$210,592
202151111$67,637
202270124$63,158
2023251377$43,321
2024486988$579,025

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks207283$457
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more245328$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more177212$58
17000Destruction of precancer skin growth, 1 growth290368$36
17003Destruction of precancer skin growth, 2-14 growths2301,268$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab18504$256,691
OtezlaApremilast18538$84,853
Dupixent PenDupilumab18560$76,297
Clobetasol PropionateClobetasol Propionate541,388$2,124
Triamcinolone AcetonideTriamcinolone Acetonide1053,206$1,704

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.94$2,040ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Luke Stewart Wallis, MD?

Tedicare shows public-source Medicare data for Luke Stewart Wallis, MD (NPI 1144724717), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Luke Stewart Wallis, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Luke Stewart Wallis, MD?

Luke Stewart Wallis, MD is linked to WALLIS DERMATOLOGY ASSOCIATES PLLC (billing NPI 1396945234) in the available physician profile data.

Does Luke Stewart Wallis, MD have Open Payments data?

Luke Stewart Wallis, MD has 94 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.